Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-06-048390
Filing Date
2006-03-08
Accepted
2006-03-08 16:25:57
Documents
8
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 919245
2 AMENDED AND RESTATED INCENTIVE STOCK OPTION AND NONSTATUTORY STOCK OPTION PLAN dex1023.htm EX-10.23 55556
3 SUBSIDIARIES dex21.htm EX-21 4427
4 CONSENT OF ERNST & YOUNG LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex23.htm EX-23 3446
5 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 7184
6 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 7176
7 SECTION 906 CEO CERTIFICATION dex321.htm EX-32.1 2704
8 SECTION 906 CFO CERTIFICATION dex322.htm EX-32.2 2669
  Complete submission text file 0001193125-06-048390.txt   1003982
Mailing Address PO BOX 13989 RESEARCH TRIANGLE PK NC 27709
Business Address 1040 SWABIA COURT DURHAM NC 27703 9199415185
EMBREX INC /NC/ (Filer) CIK: 0000878725 (see all company filings)

EIN.: 561469825 | State of Incorp.: NC | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-19495 | Film No.: 06673430
SIC: 2836 Biological Products, (No Diagnostic Substances)